A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability
Overview
Authors
Affiliations
The high frequency with which the novel tumor suppressor RASSF1A is inactivated by promoter methylation suggests that it plays a key role in the development of many primary human tumors. Yet the mechanism of RASSF1A action remains unknown. We now show that RASSF1A associates with microtubules and that this association is essential for RASSF1A to mediate its growth inhibitory effects. Overexpression of RASSF1A promotes the formation of stable microtubules, whereas a dominant-negative fragment of RASSF1A destabilizes microtubule networks. The RASSF1 protein is expressed as two main isoforms, 1A and 1C. The smaller 1C isoform also associates with microtubules but is less effective at stabilizing them. Because RASSF1A and RASSF1C localize to the mitotic spindle, we examined their effects upon genomic instability. RASSF1A and RASSF1C block activated Ras-induced genomic instability. However, a point mutant of RASSF1C, identified in human tumors, was severely defective for stabilizing tubulin and was unable to block the genomic destabilizing effects of Ras. Thus, we identify a role for RASSF1A/C in the control of microtubule polymerization and potentially in the maintenance of genomic stability.
Applying circulating tumor DNA methylation in the diagnosis of lung cancer.
Li L, Fu K, Zhou W, Snyder M Precis Clin Med. 2022; 2(1):45-56.
PMID: 35694699 PMC: 8985769. DOI: 10.1093/pcmedi/pbz003.
Detection of Endogenous RASSF1A Interacting Proteins.
Donninger H, Harrell-Stewart D, Clark G Methods Mol Biol. 2021; 2262:303-310.
PMID: 33977485 DOI: 10.1007/978-1-0716-1190-6_18.
The RASSF1A Tumor Suppressor Binds the RasGAP DAB2IP and Modulates RAS Activation in Lung Cancer.
Harrell Stewart D, Schmidt M, Donninger H, Clark G Cancers (Basel). 2020; 12(12).
PMID: 33348649 PMC: 7766191. DOI: 10.3390/cancers12123807.
Jeon H, Oh J Front Cell Dev Biol. 2020; 8:601972.
PMID: 33195286 PMC: 7649257. DOI: 10.3389/fcell.2020.601972.
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy.
Garcia-Gutierrez L, McKenna S, Kolch W, Matallanas D Cancers (Basel). 2020; 12(1).
PMID: 31963420 PMC: 7017281. DOI: 10.3390/cancers12010229.